Two drugs better than one? study tests cholesterol combo for High-Risk hearts
NCT ID NCT05761444
Summary
This study tested if adding a second cholesterol drug, ezetimibe, to a common statin (atorvastatin) works better than the statin alone for very high-risk heart disease patients. It involved 137 adults with existing heart or blood vessel disease who needed better cholesterol control. The main goal was to see if the two-drug combination lowered 'bad' cholesterol (LDL-C) more effectively after 6 and 12 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Chonnam National University Hospital
Gwangju, Jeollanam-do, 61469, South Korea
-
Eunpyeong St. Mary's Hospital
Seoul, Eunpyeong-gu, 03312, South Korea
-
Inje University Ilsan-Paik Hospital
Goyang-si, Gyeonggi-do, 10380, South Korea
-
Kangbuk Samsung Hospital
Seoul, 03181, South Korea
-
Keimyung University Dongsan Medical Center
Daegu, Gyeongsangbuk-do, 42601, South Korea
-
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 13620, South Korea
-
Ulsan University Hospital
Ulsan, Gyeongsangnam-do, 44033, South Korea
Conditions
Explore the condition pages connected to this study.